RT Journal Article
SR Electronic
A1 Parry, Nicola
T1 Higher Doses of Levomilnacipran May Benefit Patients with Severe Depression
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 8
SP 20
OP 20
DO 10.1177/155989771408012
UL http://mdc.sagepub.com/content/14/8/20.1.abstract
AB This article presents a poster with results of a Phase 3 trial to evaluate the efficacy and tolerability of levomilnacipran extended-release (ER) dose in adult patients with major depressive disorder [APA 2014 (poster NR6-087); NCT00969709]. The results of the study indicated that higher doses of levomilnacipran ER may benefit some patients, including those with moderate to severe depression.